Orbital Therapeutics is pioneering the development of next-generation RNA-based medicines. The company focuses on advancing RNA technology, particularly in vaccines, immunomodulation, and protein replacement. Their innovative platform integrates RNA technology with advanced delivery methods, data science, and automation to create transformative treatments. Founded by leading experts in genetic medicine, Orbital Therapeutics aims to push the boundaries of RNA therapeutics to address unmet medical needs.
Founded: 2021
Giuseppe Ciaramell, PhD Co-Founder, CEO |
Giles Besin, PhD Chief Scientific Officer |
Niru Subramanian COO |
Jonahtan Piazza CFO |
John Maraganore, PhD Chairman and Co-Founder |
Kristina Burow Director and Co-Founder |
Carol Suh Director and Co-Founder |